SEC FORM 4
$62,957.64
Allogene Therapeutics, Inc. (ALLO)
Sale of 29,697 shares at $2.12 per share.
Reporting Person Douglas Earl Martin · Officer Title SVP, General Counsel · Transaction Code S
Traded Aug 21, 2026 · Disclosed Aug 25, 2026
Source: SEC Form 4 · 0001628280-26-058920 · filed 2026-08-25 · View filing →